Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies

Vaccine

Volumn 32, Issue 29, 2014, Pages 3623-3629

  Taylor, Luke E ^a   Swerdfeger, Amy L ^a   Eslick, Guy D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Autism; Autism spectrum disorder; Immunisation; Mercury; Thimerosal; Vaccination; Vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MERCURY; THIOMERSAL; VACCINE; PRESERVATIVE;

ARTICLE; AUTISM; CASE CONTROL STUDY; COHORT ANALYSIS; EVIDENCE BASED PRACTICE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLIC HEALTH; VACCINATION; CHEMICALLY INDUCED; PUBLISHING;

AUTISTIC DISORDER; CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE; MERCURY; PRESERVATIVES, PHARMACEUTICAL; PUBLICATION BIAS; THIMEROSAL; VACCINATION;

EID: 84901636483     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.085     Document Type: Article

References (36)

1. Center for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMWR). Measles- United States, 2011. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6115a1.htm?s_cid=mm6115a1_w#fig1. Accessibility verified October 30, 2013.
2. NSW Government Health. Measles Notifications in NSW Residents. Available at: http://www0.health.nsw.gov.au/data/diseases/measles.asp. Accessibility verified October 30, 2013.
3. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
4. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
5. Varricchio F., Iskander J., Destefano F., Ball R., Pless R., Braun M., Chen R.T. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004, 23:287-294.
6. Goodman M.J., Nordin J. Vaccine Adverse Event Reporting System reporting source: a possible source of bias in longitudinal studies. Pediatrics 2006, 117:387-390.
7. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non Randomised Studies in Meta-Analyses, Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp, (accessed July 16, 2013).
8. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986, 7:177-188.
9. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
10. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
11. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull 1979, 85:638-641.
12. Madsen K.M., Hviid A., Vestergaard M., et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002, 347(19):1477-1482.
13. Uchiyama T., Kurosawa M., Inaba Y. MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan. J Autism Dev Disord 2007, 37:210-217.
14. Andrews N., Miller E., Grant A., Stowe J., Osborne V., Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004, 114(3):584-591.
15. Verstraeten T., Davis R.L., DeStefano F., et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003, 112(5):1039-1048.
16. Hviid A., Stellfeld M., Wohlfahrt J., Melbye M. Association between thimerosal-containing vaccine and autism. JAMA 2003, 290(13):1763-1766.
17. DeStefano F., Bhasin T.K., Thompson W.W., Yeargin-Allsopp M., Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics 2004, 113(2):259-266.
18. Mrozek-Budzyn D., Kiełtyka A., Majewska R. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Pediatr Infect Dis J 2010, 29(5):397-400.
19. Smeeth L., Cook C., Fombonne E., Heavey L., Rodrigues L.C., Smith P.G., Hall A.J. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 2004, 364:963-969.
20. Smeeth L., Hall A.J., Fombonne E., Rodrigues L.C., Huang X., Smith P.G. A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. BMC Public Health 2001, 1:2.
21. Uno Y., Uchiyama T., Kurosawa M., Aleksic B., Ozaki N. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine 2012, 30:4292-4298.
22. Price C.S., Thompson W.W., Goodson B., et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 2010, 126(4):656-664.
23. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
24. Almazrou A.M. MMR vaccine and autism: is there a link?. Curr Pediatr Res 2006, 10(1-2):5-8.
25. Demicheli V., Rivetti A., Debalini M.G., Di Pietrantonj C. Vaccines for measles, mumps and rubella in children (review). Cochrane Database Syst Rev 2012, 2:CD004407. 10.1002/14651858.CD004407.pub3.
26. Jefferson T., Price D., Demicheli V., Bianco E. Unintended events following immunization with MMR: a systematic review. Vaccine 2003, 21(25-26):3954-3960.
27. Kimmel S.R., Burns I.T., Wolfe R.M., Zimmerman R.K. Addressing immunization barriers, benefits, and risks. J Fam Pract 2007, 56(Suppl. 2 vaccines):S61-S69.
28. Klein K.C., Diehl E.B. Relationship between MMR vaccine and autism. Ann Pharmacother 2004, 38(7-8):1297-1300.
29. Mutter J., Naumann J., Schneider R., Walach H., Haley B. Mercury and autism: accelerating evidence?. Neuro Endocrinol Lett 2005, 26(5):439-446.
30. Örtqvist Å., Blennow M., Carlsson R.-M., et al. Vaccination of children-a systematic review. Acta Paediatr 2010, 99(461):1-192.
31. Parker S.K., Schwartz B., Todd J., Pickering L.K. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 2004, 114(3):793-804.
32. Ratajczak H.V. Theoretical aspects of autism: causes-a review. J Immunotoxicol 2011, 8(1):68-79.
33. Rutter M. Aetiology of autism: findings and questions. J Intellect Disabil Res 2005, 49(4):231-238.
34. Sengupta N., Bedford H., Elliman D., Booy R. Does the MMR triple vaccine cause autism?. Evid Based Healthc Public Health 2004, 8:239-245.
35. Wilson K., Mills E., Ross C., McGowan J., Jadad A. Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence. Arch Pediatr Adolesc Med 2003, 157(7):628-634.
36. Taylor B., Miller E., Lingram L., Andrews N., Simmons A., Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002, 324:393-396.